论文部分内容阅读
豪森药业集团创建于1995年7月,目前已发展成为集化学、生物药物研究,医药中间体、原料药合成,制剂制造和产品销售于—体的创新型医药集团,是国家最早评定的重点高新技术企业,国内最大的抗肿瘤和精神类药物研发和和生产基地之一,2014年度位列“中国制药工业百强榜”第19位,“豪森”为“中国驰名商标”。豪森高度重视新产品研发,位于连云港的豪森研究院,总建筑面积3 5000平方米,设有化学、生物、制剂开发、工艺、药理毒理、中试等多个研发部门,是国家认定的企业技术中心,设有国家级博
Founded in July 1995, the Hosen Pharmaceutical Group has developed into an innovative pharmaceutical conglomerate that integrates chemical, biopharmaceutical research, pharmaceutical intermediates, bulk drug synthesis, formulation manufacturing and product sales. It is the earliest assessment of the country Key high-tech enterprise, one of the largest research and development and production bases of anti-tumor and psychotropic drugs in China, ranking the 19th in “Top 100 Chinese Pharmaceutical Industry” in 2014 and “ Well-known trademarks ”. Hausen attaches great importance to the development of new products, located in the Howe Institute of Lianyungang, with a total construction area of 3 5000 square meters, with a number of R & D department of chemical, biological, preparation development, technology, pharmacology and toxicology, pilot and other countries, Enterprise Technology Center, with a national Bo